Abstract
The cerebral ischemia is one of the most common diseases in the central nervous system that causes progressive disability or even death. In this connection, the inflammatory response mediated by the activated microglia is believed to play a central role in this pathogenesis. In the event of brain injury, activated microglia can clear the cellular debris and invading pathogens, release neurotrophic factors, etc., but in chronic activation microglia may cause neuronal death through the release of excessive inflammatory mediators. Therefore, suppression of microglial over-reaction and microglia-mediated neuroinflammation is deemed to be a therapeutic strategy of choice for cerebral ischemic damage. In the search for potential herbal extracts that are endowed with the property in suppressing the microglial activation and amelioration of neuroinflammation, attention has recently been drawn to scutellarin, a Chinese herbal extract. Here, we review the roles of activated microglia and the effects of scutellarin on activated microglia in pathological conditions especially in ischemic stroke. We have further extended the investigation with special reference to the effects of scutellarin on Notch signaling, one of the several signaling pathways known to be involved in microglial activation. Furthermore, in light of our recent experimental evidence that activated microglia can regulate astrogliosis, an interglial “cross-talk” that was amplified by scutellarin, it is suggested that in designing of a more effective therapeutic strategy for clinical management of cerebral ischemia both glial types should be considered collectively.
Similar content being viewed by others
Abbreviations
- Aβ:
-
β-amyloid peptide
- AD:
-
Alzheimer’s disease
- BBB:
-
Blood–brain barrier
- CNS:
-
Central nervous system
- DAPT:
-
N-[N-(3,5-difluorophenacetyl)-1-alany1]-S-phenyglycine t-butyl ester
- GFAP:
-
Glial fibrillary acidic protein
- Hes-1:
-
Transcription factor hairy and enhancer of split-1
- IL-1β:
-
Interleukin-1β
- Inos:
-
Inducible nitric oxide synthase
- LPS:
-
Lipopolysaccharide
- MCAO:
-
Middle cerebral artery occlusion
- NF-κB:
-
Nuclear factor κ-light-chain-enhancer of activated B cells
- NICD:
-
Notch intracellular domain
- NO:
-
Nitric oxide
- RBP-JK:
-
Recombining binding protein suppressor of hairless
- ROS:
-
Reactive oxygen species
- TNF-α:
-
Tumor necrosis factor-α
References
Amantea, D., Nappi, G., Bernardi, G., Bagetta, G., & Corasaniti, M. T. (2009). Post-ischemic brain damage: Pathophysiology and role of inflammatory mediators. FEBS Journal, 276(1), 13–26. doi:10.1111/j.1742-4658.2008.06766.x.
Anderson, M. F., Blomstrand, F., Blomstrand, C., Eriksson, P. S., & Nilsson, M. (2003). Astrocytes and stroke: Networking for survival? Neurochemical Research, 28(2), 293–305.
Ang, H. L., & Tergaonkar, V. (2007). Notch and NFκB signaling pathways: Do they collaborate in normal vertebrate brain development and function? BioEssays, 29(10), 1039–1047. doi:10.1002/bies.20647.
Arumugam, T. V., Chan, S. L., Jo, D. G., Yilmaz, G., Tang, S. C., Cheng, A., et al. (2006). Gamma secretase-mediated Notch signaling worsens brain damage and functional outcome in ischemic stroke. Nature Medicin, 12(6), 621–623. doi:10.1038/nm1403.
Beckman, J. S., & Koppenol, W. H. (1996). Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. The American Journal of Physiology, 271(5 Pt 1), C1424–C1437.
Brabers, N. A., & Nottet, H. S. (2006). Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. European Journal of Clinical Investigation, 36(7), 447–458. doi:10.1111/j.1365-2362.2006.01657.x.
Candelario-Jalil, E. (2009). Injury and repair mechanisms in ischemic stroke: Considerations for the development of novel neurotherapeutics. Current Opinion in Investigational Drugs, 10(7), 644–654.
Cao, Q., Li, P., Lu, J., Dheen, S. T., Kaur, C., & Ling, E. A. (2010). Nuclear factor-κB/p65 responds to changes in the Notch signaling pathway in murine BV-2 cells and in amoeboid microglia in postnatal rats treated with the gamma-secretase complex blocker DAPT. Journal of Neuroscience Research, 88(12), 2701–2714. doi:10.1002/jnr.22429.
Cao, Q., Lu, J., Kaur, C., Sivakumar, V., Li, F., Cheah, P. S., et al. (2008). Expression of Notch-1 receptor and its ligands Jagged-1 and Delta-1 in amoeboid microglia in postnatal rat brain and murine BV-2 cells. Glia, 56(11), 1224–1237. doi:10.1002/glia.20692.
Chai, L., Guo, H., Li, H., Wang, S., Wang, Y. L., Shi, F., et al. (2013). Scutellarin and caffeic acid ester fraction, active components of Dengzhanxixin injection, upregulate neurotrophins synthesis and release in hypoxia/reoxygenation rat astrocytes. Journal of Ethnopharmacology, 150(1), 100–107. doi:10.1016/j.jep.2013.08.011.
Chan, J. Y., Tan, B. K., & Lee, S. C. (2009). Scutellarin sensitizes drug-evoked colon cancer cell apoptosis through enhanced caspase-6 activation. Anticancer Research, 29(8), 3043–3047.
Chen, X., Shi, X., Zhang, X., Lei, H., Long, S., Su, H., et al. (2013). Scutellarin attenuates hypertension-induced expression of brain toll-like receptor 4/nuclear factor kappa B. Mediators of Inflammation, 2013, 432623. doi:10.1155/2013/432623.
Christov, A., Ottman, J. T., & Grammas, P. (2004). Vascular inflammatory, oxidative and protease-based processes: implications for neuronal cell death in Alzheimer’s disease. Neurological Research, 26(5), 540–546. doi:10.1179/016164104225016218.
Czeh, M., Gressens, P., & Kaindl, A. M. (2011). The yin and yang of microglia. Developmental Neuroscience, 33(3–4), 199–209. doi:10.1159/000328989.
D’Acquisto, F., May, M. J., & Ghosh, S. (2002). Inhibition of nuclear factor kappa B (NF-B): an emerging theme in anti-inflammatory therapies. Molecular Interventions, 2(1), 22–35. doi:10.1124/mi.2.1.22.
del Zoppo, G. J., Sharp, F. R., Heiss, W. D., & Albers, G. W. (2011). Heterogeneity in the penumbra. Journal of Cerebral Blood Flow and Metabolism, 31(9), 1836–1851. doi:10.1038/jcbfm.2011.93.
Denes, A., Vidyasagar, R., Feng, J., Narvainen, J., McColl, B. W., Kauppinen, R. A., et al. (2007). Proliferating resident microglia after focal cerebral ischaemia in mice. Journal of Cerebral Blood Flow and Metabolism, 27(12), 1941–1953. doi:10.1038/sj.jcbfm.9600495.
Dheen, S. T., Kaur, C., & Ling, E. A. (2007). Microglial activation and its implications in the brain diseases. Current Medicinal Chemistry, 14(11), 1189–1197.
Durukan, A., & Tatlisumak, T. (2007). Acute ischemic stroke: Overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacology, Biochemistry and Behavior, 87(1), 179–197. doi:10.1016/j.pbb.2007.04.015.
Ekdahl, C. T., Kokaia, Z., & Lindvall, O. (2009). Brain inflammation and adult neurogenesis: The dual role of microglia. Neuroscience, 158(3), 1021–1029. doi:10.1016/j.neuroscience.2008.06.052.
Fang, M., Yuan, Y., Rangarajan, P., Lu, J., Wu, Y., Wang, H., et al. (2015). Scutellarin regulates microglia-mediated TNC1 astrocytic reaction and astrogliosis in cerebral ischemia in the adult rats. BMC Neuroscience, 16(1), 84. doi:10.1186/s12868-015-0219-6.
Feng, Y., Zhang, S., Tu, J., Cao, Z., Pan, Y., Shang, B., et al. (2012). Novel function of scutellarin in inhibiting cell proliferation and inducing cell apoptosis of human Burkitt lymphoma Namalwa cells. Leukemia & Lymphoma, 53(12), 2456–2464. doi:10.3109/10428194.2012.693177.
Gregersen, R., Lambertsen, K., & Finsen, B. (2000). Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. Journal of Cerebral Blood Flow and Metabolism, 20(1), 53–65. doi:10.1097/00004647-200001000-00009.
Guo, L. L., Guan, Z. Z., Huang, Y., Wang, Y. L., & Shi, J. S. (2013). The neurotoxicity of beta-amyloid peptide toward rat brain is associated with enhanced oxidative stress, inflammation and apoptosis, all of which can be attenuated by scutellarin. Experimental and Toxicologic Pathology, 65(5), 579–584. doi:10.1016/j.etp.2012.05.003.
Guo, L. L., Guan, Z. Z., & Wang, Y. L. (2011a). Scutellarin protects against Abeta-induced learning and memory deficits in rats: Involvement of nicotinic acetylcholine receptors and cholinesterase. Acta Pharmacologica Sinica, 32(12), 1446–1453. doi:10.1038/aps.2011.115.
Guo, H., Hu, L. M., Wang, S. X., Wang, Y. L., Shi, F., Li, H., et al. (2011b). Neuroprotective effects of scutellarin against hypoxic-ischemic-induced cerebral injury via augmentation of antioxidant defense capacity. The Chinese Journal of Physiology, 54(6), 399–405. doi:10.4077/CJP.2011.AMM059.
Han, Y. L., Li, D., Yang, Q. J., Zhou, Z. Y., Liu, L. Y., Li, B., et al. (2014). In vitro inhibitory effects of scutellarin on six human/rat cytochrome P450 enzymes and P-glycoprotein. Molecules, 19(5), 5748–5760. doi:10.3390/molecules19055748.
Hong, H., & Liu, G. Q. (2004). Protection against hydrogen peroxide-induced cytotoxicity in PC12 cells by scutellarin. Life Sciences, 74(24), 2959–2973. doi:10.1016/j.lfs.2003.09.074.
Hosomi, N., Ban, C. R., Naya, T., Takahashi, T., Guo, P., Song, X. Y., et al. (2005). Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism, 25(8), 959–967. doi:10.1038/sj.jcbfm.9600086.
Hossmann, K. A. (2006). Pathophysiology and therapy of experimental stroke. Cellular and Molecular Neurobiology, 26(7–8), 1057–1083. doi:10.1007/s10571-006-9008-1.
Huang, J., Li, N., Yu, Y., Weng, W., & Huang, X. (2006a). Determination of aglycone conjugated metabolites of scutellarin in rat plasma by HPLC. Journal of Pharmaceutical and Biomedical Analysis, 40(2), 465–471. doi:10.1016/j.jpba.2005.07.051.
Huang, J., Upadhyay, U. M., & Tamargo, R. J. (2006b). Inflammation in stroke and focal cerebral ischemia. Surgical Neurology, 66(3), 232–245. doi:10.1016/j.surneu.2005.12.028.
Iadecola, C., Zhang, F., & Xu, X. (1995). Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. The American Journal of Physiology, 268(1 Pt 2), R286–R292.
Jin, R., Yang, G., & Li, G. (2010). Inflammatory mechanisms in ischemic stroke: Role of inflammatory cells. Journal of Leukocyte Biology, 87(5), 779–789. doi:10.1189/jlb.1109766.
Kaur, C., Ling, E. A., & Wong, W. C. (1985). Transformation of amoeboid microglial cells into microglia in the corpus callosum of the postnatal rat brain. An electron microscopical study. Archivum Histologicum Japonicum, 48(1), 17–25.
Komitova, M., Perfilieva, E., Mattsson, B., Eriksson, P. S., & Johansson, B. B. (2002). Effects of cortical ischemia and postischemic environmental enrichment on hippocampal cell genesis and differentiation in the adult rat. Journal of Cerebral Blood Flow and Metabolism, 22(7), 852–860. doi:10.1097/00004647-200207000-00010.
Kowalska, A. (2004). The beta-amyloid cascade hypothesis: A sequence of events leading to neurodegeneration in Alzheimer’s disease. Neurologia i Neurochirurgia Polska, 38(5), 405–411.
Lai, A. Y., & Todd, K. G. (2006). Microglia in cerebral ischemia: Molecular actions and interactions. Canadian Journal of Physiology and Pharmacology, 84(1), 49–59. doi:10.1139/Y05-143.
Lalancette-Hebert, M., Gowing, G., Simard, A., Weng, Y. C., & Kriz, J. (2007). Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. Journal of Neuroscience, 27(10), 2596–2605. doi:10.1523/JNEUROSCI.5360-06.2007.
Lambertsen, K. L., Clausen, B. H., Babcock, A. A., Gregersen, R., Fenger, C., Nielsen, H. H., et al. (2009). Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. Journal of Neuroscience, 29(5), 1319–1330. doi:10.1523/JNEUROSCI.5505-08.2009.
Legos, J. J., Whitmore, R. G., Erhardt, J. A., Parsons, A. A., Tuma, R. F., & Barone, F. C. (2000). Quantitative changes in interleukin proteins following focal stroke in the rat. Neuroscience Letters, 282(3), 189–192.
Li, H., Huang, D., Gao, Z., Chen, Y., Zhang, L., & Zheng, J. (2013a). Scutellarin inhibits the growth and invasion of human tongue squamous carcinoma through the inhibition of matrix metalloproteinase-2 and -9 and αvβ6 integrin. International Journal of Oncology, 42(5), 1674–1681. doi:10.3892/ijo.2013.1873.
Li, L., Li, L., Chen, C., Yang, J., Li, J., Hu, N., et al. (2015). Scutellarin’s cardiovascular endothelium protective mechanism: Important role of PKG-Iα. PLoS one, 10(10), e0139570. doi:10.1371/journal.pone.0139570.
Li, J. H., Lu, J., & Zhang, H. (2013b). Functional recovery after scutellarin treatment in transient cerebral ischemic rats: A pilot study with (18) F-fluorodeoxyglucose MicroPET. Evidence Based Complementary and Alternative Medicine, 2013, 507091. doi:10.1155/2013/507091.
Li, X., Wang, L., Li, Y., Bai, L., & Xue, M. (2011). Acute and subacute toxicological evaluation of scutellarin in rodents. Regulatory Toxicology and Pharmacology, 60(1), 106–111. doi:10.1016/j.yrtph.2011.02.013.
Li, Q., Wu, J. H., Guo, D. J., Cheng, H. L., Chen, S. L., & Chan, S. W. (2009). Suppression of diet-induced hypercholesterolemia by scutellarin in rats. Planta Medica, 75(11), 1203–1208. doi:10.1055/s-0029-1185539.
Ling, E. A., & Wong, W. C. (1993). The origin and nature of ramified and amoeboid microglia: A historical review and current concepts. Glia, 7(1), 9–18. doi:10.1002/glia.440070105.
Liu, H., Yang, X., Tang, R., Liu, J., & Xu, H. (2005). Effect of scutellarin on nitric oxide production in early stages of neuron damage induced by hydrogen peroxide. Pharmacological Research, 51(3), 205–210. doi:10.1016/j.phrs.2004.09.001.
Liu, H. C., Zheng, M. H., Du, Y. L., Wang, L., Kuang, F., Qin, H. Y., et al. (2012). N9 microglial cells polarized by LPS and IL4 show differential responses to secondary environmental stimuli. Cellular Immunology, 278(1–2), 84–90. doi:10.1016/j.cellimm.2012.06.001.
Long, L., Wang, J., Lu, X., Xu, Y., Zheng, S., Luo, C., et al. (2015). Protective effects of scutellarin on type II diabetes mellitus-induced testicular damages related to reactive oxygen species/Bcl-2/Bax and reactive oxygen species/microcirculation/staving pathway in diabetic rat. Journal of Diabetes Research, 2015, 252530. doi:10.1155/2015/252530.
McCoy, M. K., & Tansey, M. G. (2008). TNF signaling inhibition in the CNS: Implications for normal brain function and neurodegenerative disease. Journal of Neuroinflammation, 5, 45. doi:10.1186/1742-2094-5-45.
Morrison, H. W., & Filosa, J. A. (2013). A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion. Journal of Neuroinflammation, 10, 4. doi:10.1186/1742-2094-10-4.
Neher, J. J., Emmrich, J. V., Fricker, M., Mander, P. K., Thery, C., & Brown, G. C. (2013). Phagocytosis executes delayed neuronal death after focal brain ischemia. Proceedings of the National Academy of Sciences of the United States of America, 110(43), E4098–E4107. doi:10.1073/pnas.1308679110.
Neumann, H., Kotter, M. R., & Franklin, R. J. (2009). Debris clearance by microglia: an essential link between degeneration and regeneration. Brain, 132(Pt 2), 288–295. doi:10.1093/brain/awn109.
Northington, F. J., Zelaya, M. E., O’Riordan, D. P., Blomgren, K., Flock, D. L., Hagberg, H., et al. (2007). Failure to complete apoptosis following neonatal hypoxia-ischemia manifests as “continuum” phenotype of cell death and occurs with multiple manifestations of mitochondrial dysfunction in rodent forebrain. Neuroscience, 149(4), 822–833. doi:10.1016/j.neuroscience.2007.06.060.
Pan, Z. W., Zhang, Y., Mei, D. H., Zhang, R., Wang, J. H., Zhang, X. Y., et al. (2010). Scutellarin exerts its anti-hypertrophic effects via suppressing the Ca2+-mediated calcineurin and CaMKII signaling pathways. Naunyn-Schmiedeberg’s Archives of Pharmacology, 381(2), 137–145. doi:10.1007/s00210-009-0484-y.
Park, K. M., Yule, D. I., & Bowers, W. J. (2008). Tumor necrosis factor-alpha potentiates intraneuronal Ca2+ signaling via regulation of the inositol 1,4,5-trisphosphate receptor. Journal of Biological Chemistry, 283(48), 33069–33079. doi:10.1074/jbc.M802209200.
Pettigrew, L. C., Kindy, M. S., Scheff, S., Springer, J. E., Kryscio, R. J., Li, Y., et al. (2008). Focal cerebral ischemia in the TNFα-transgenic rat. Journal of Neuroinflammation, 5, 47. doi:10.1186/1742-2094-5-47.
Ponomarev, E. D., Veremeyko, T., & Weiner, H. L. (2013). MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia, 61(1), 91–103. doi:10.1002/glia.22363.
Regenhardt, R. W., Desland, F., Mecca, A. P., Pioquinto, D. J., Afzal, A., Mocco, J., et al. (2013). Anti-inflammatory effects of angiotensin-(1-7) in ischemic stroke. Neuropharmacology, 71, 154–163. doi:10.1016/j.neuropharm.2013.03.025.
Schwarzer, R., Dorken, B., & Jundt, F. (2012). Notch is an essential upstream regulator of NF-κB and is relevant for survival of Hodgkin and Reed-Sternberg cells. Leukemia, 26(4), 806–813. doi:10.1038/leu.2011.265.
Shin, W. H., Lee, D. Y., Park, K. W., Kim, S. U., Yang, M. S., Joe, E. H., et al. (2004). Microglia expressing interleukin-13 undergo cell death and contribute to neuronal survival in vivo. Glia, 46(2), 142–152. doi:10.1002/glia.10357.
Simi, A., Tsakiri, N., Wang, P., & Rothwell, N. J. (2007). Interleukin-1 and inflammatory neurodegeneration. Biochemical Society Transactions, 35(Pt 5), 1122–1126. doi:10.1042/BST0351122.
Spooren, A., Kolmus, K., Laureys, G., Clinckers, R., De Keyser, J., Haegeman, G., et al. (2011). Interleukin-6, a mental cytokine. Brain Research Reviews, 67(1–2), 157–183. doi:10.1016/j.brainresrev.2011.01.002.
Sriram, K., & O’Callaghan, J. P. (2007). Divergent roles for tumor necrosis factor-alpha in the brain. Journal of Neuroimmune Pharmacology, 2(2), 140–153. doi:10.1007/s11481-007-9070-6.
Stidworthy, M. F., Genoud, S., Li, W. W., Leone, D. P., Mantei, N., Suter, U., et al. (2004). Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. Brain, 127(Pt 9), 1928–1941. doi:10.1093/brain/awh217.
Stone, B. S., Zhang, J., Mack, D. W., Mori, S., Martin, L. J., & Northington, F. J. (2008). Delayed neural network degeneration after neonatal hypoxia-ischemia. Annals of Neurology, 64(5), 535–546. doi:10.1002/ana.21517.
Takeuchi, H., Jin, S., Suzuki, H., Doi, Y., Liang, J., Kawanokuchi, J., et al. (2008). Blockade of microglial glutamate release protects against ischemic brain injury. Experimental Neurology, 214(1), 144–146. doi:10.1016/j.expneurol.2008.08.001.
Tang, H., Tang, Y., Li, N. G., Lin, H., Li, W., Shi, Q., et al. (2015). Comparative metabolomic analysis of the neuroprotective effects of scutellarin and scutellarein against ischemic insult. PLoS ONE, 10(7), e0131569. doi:10.1371/journal.pone.0131569.
Tang, H., Tang, Y., Li, N., Shi, Q., Guo, J., Shang, E., et al. (2014). Neuroprotective effects of scutellarin and scutellarein on repeatedly cerebral ischemia-reperfusion in rats. Pharmacology, Biochemistry and Behavior, 118, 51–59. doi:10.1016/j.pbb.2014.01.003.
Taylor, C. P., & Meldrum, B. S. (1995). Na+ channels as targets for neuroprotective drugs. Trends in Pharmacological Sciences, 16(9), 309–316.
Thomas, W. E. (1992). Brain macrophages: Evaluation of microglia and their functions. Brain Research Reviews, 17(1), 61–74.
Utagawa, A., Truettner, J. S., Dietrich, W. D., & Bramlett, H. M. (2008). Systemic inflammation exacerbates behavioral and histopathological consequences of isolated traumatic brain injury in rats. Experimental Neurology, 211(1), 283–291. doi:10.1016/j.expneurol.2008.02.001.
Wang, Q., Tang, X. N., & Yenari, M. A. (2007a). The inflammatory response in stroke. Journal of Neuroimmunology, 184(1–2), 53–68. doi:10.1016/j.jneuroim.2006.11.014.
Wang, D., Wang, L., Gu, J., Yang, H., Liu, N., Lin, Y., et al. (2014). Scutellarin inhibits high glucose-induced and hypoxia-mimetic agent-induced angiogenic effects in human retinal endothelial cells through reactive oxygen species/hypoxia-inducible factor-1α/vascular endothelial growth factor pathway. Journal of Cardiovascular Pharmacology, 64(3), 218–227. doi:10.1097/FJC.0000000000000109.
Wang, S., Wang, H., Guo, H., Kang, L., Gao, X., & Hu, L. (2011). Neuroprotection of Scutellarin is mediated by inhibition of microglial inflammatory activation. Neuroscience, 185, 150–160. doi:10.1016/j.neuroscience.2011.04.005.
Wang, L. X., Zeng, J. P., Wei, X. B., Wang, F. W., Liu, Z. P., & Zhang, X. M. (2007b). Effects of scutellarin on apoptosis induced by cobalt chloride in PC12 cells. The Chinese journal of Physiology, 50(6), 301–307.
Wei, Z., Chigurupati, S., Arumugam, T. V., Jo, D. G., Li, H., & Chan, S. L. (2011). Notch activation enhances the microglia-mediated inflammatory response associated with focal cerebral ischemia. Stroke, 42(9), 2589–2594. doi:10.1161/STROKEAHA.111.614834.
Wiart, M., Davoust, N., Pialat, J. B., Desestret, V., Moucharrafie, S., Cho, T. H., et al. (2007). MRI monitoring of neuroinflammation in mouse focal ischemia. Stroke, 38(1), 131–137. doi:10.1161/01.STR.0000252159.05702.00.
Xu, H., & Zhang, S. (2013). Scutellarin-induced apoptosis in HepG2 hepatocellular carcinoma cells via a STAT3 pathway. Phytotherapy Research, 27(10), 1524–1528. doi:10.1002/ptr.4892.
Yao, L., Cao, Q., Wu, C., Kaur, C., Hao, A., & Ling, E. A. (2013a). Notch signaling in the central nervous system with special reference to its expression in microglia. CNS & Neurological Disorders: Drug Targets, 12(6), 807–814.
Yao, L., Kan, E. M., Kaur, C., Dheen, S. T., Hao, A., Lu, J., et al. (2013b). Notch-1 signaling regulates microglia activation via NF-κB pathway after hypoxic exposure in vivo and in vitro. PLoS one, 8(11), e78439. doi:10.1371/journal.pone.0078439.
Yuan, Y., Rangarajan, P., Kan, E., Wu, Y., Wu, C., & Ling, E. A. (2015). Scutellarin regulates the Notch pathway and affects the migration and morphological transformation of activated microglia in experimentally induced cerebral ischemia in rats and in activated BV-2 microglia. Journal of Neuroinflammation, 12(1), 11. doi:10.1186/s12974-014-0226-z.
Yuan, Y., Zha, H., Rangarajan, P., Ling, E. A., & Wu, C. (2014). Anti-inflammatory effects of Edaravone and Scutellarin in activated microglia in experimentally induced ischemia injury in rats and in BV-2 microglia. BMC Neuroscience, 15(1), 125. doi:10.1186/s12868-014-0125-3.
Zhang, W., Dong, Z. X., Gu, T., Li, N. G., Zhang, P. X., Wu, W. Y., et al. (2015). A new and efficient synthesis of 6-O-methylscutellarein, the major metabolite of the natural medicine scutellarin. Molecules, 20(6), 10184–10191. doi:10.3390/molecules200610184.
Zhang, H. F., Hu, X. M., Wang, L. X., Xu, S. Q., & Zeng, F. D. (2009). Protective effects of scutellarin against cerebral ischemia in rats: Evidence for inhibition of the apoptosis-inducing factor pathway. Planta Medica, 75(2), 121–126. doi:10.1055/s-0028-1088368.
Zhang, G., Qiu, S., & Wei, H. (2011). Scutellarin blocks sodium current in freshly isolated mouse hippocampal CA1 neurons. Neurochemical Research, 36(6), 947–954. doi:10.1007/s11064-011-0426-1.
Zhou, X., Spittau, B., & Krieglstein, K. (2012). TGFβ signalling plays an important role in IL4-induced alternative activation of microglia. Journal of Neuroinflammation, 9, 210. doi:10.1186/1742-2094-9-210.
Zhou, M., Wang, C. M., Yang, W. L., & Wang, P. (2013). Microglial CD14 activated by iNOS contributes to neuroinflammation in cerebral ischemia. Brain Research, 1506, 105–114. doi:10.1016/j.brainres.2013.02.010.
Zhu, J. T., Choi, R. C., Li, J., Xie, H. Q., Bi, C. W., Cheung, A. W., et al. (2009). Estrogenic and neuroprotective properties of scutellarin from Erigeron breviscapus: A drug against postmenopausal symptoms and Alzheimer’s disease. Planta Medica, 75(14), 1489–1493. doi:10.1055/s-0029-1185776.
Acknowledgments
This study was supported by National Natural Science Foundation of China (Project Number 31260254, C-Y Wu), Applied Basic Research Program Key Projects of Yunnan Province (Project Number 2015FA020, C-Y Wu), and National University of Singapore (NUS R181-000-140-592, E-A Ling).
Author’s contributions
Eng-Ang Ling and Chunyun Wu conceptualized this review. Yun Yuan and Ming Fang conducted the experiments mentioned in this review. Yun Yuan led to write the manuscript, and Ming Fang was responsible for submitting the final manuscript. All authors read, discussed, and approved the final manuscript.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest. All authors have read and approved the manuscript.
Additional information
Yun Yuan and Ming Fang have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Yuan, Y., Fang, M., Wu, CY. et al. Scutellarin as a Potential Therapeutic Agent for Microglia-Mediated Neuroinflammation in Cerebral Ischemia. Neuromol Med 18, 264–273 (2016). https://doi.org/10.1007/s12017-016-8394-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12017-016-8394-x